Industry Insights
Contraceptive drugs and devices market is expected to grow over the forecast period owing to the increasing prevalence of sexually transmitted diseases such as HIV & HPV and growing population. The other drivers of this market are increasing government & NGO’s programs against the abortion, social & political consideration, and changing lifestyle. Contraceptive drugs & devices are the commonly known for birth and fertility control and are used to avoid pregnancy. Function of these devices & drugs is to change ovulation mechanism by acting as a physical barrier between ovum and sperm. Lack of contraception results have impacted on healthcare costs due to the unwanted abortions and pregnancies. The usage, planning and provisions of contraceptives are known as family planning. There are various advantages attached to the contraceptive drugs & devices as it helps in the prevention of spread of sexually transmitted diseases. Family planning includes application of intra-uterine devices, sterilization, hormonal barrier as a method for birth control. Apart from these, there are emergency controls, dual protection and behavioral are available for prevention of pregnancy.
Global market for contraceptives encompasses female contraceptive devices, male contraceptive devices, and vaginal, oral, and injectable contraceptive drugs. These contraceptive devices and drugs are available globally in almost all the outlets ranging from chemists, pharmacies, fertility centers and reproductive health centers. All the sexually active females at childbearing age are at a risk of unwanted pregnancies due to unsafe sex. There has been tremendous growth in the sexually transmitted diseases sector and the global population, due to the lack of awareness about the contraceptive drugs and devices. All these have generated awareness among the people to curb unplanned and unwanted pregnancies. This market has a huge unmet opportunity over the forecast period.
Product Insights
Contraceptive drugs and devices market is segmented on the basis of product types into contraceptive drugs, female contraceptive devices, and male contraceptive devices. Among these, largest share is held by contraceptive drugs as of 2014, as it is easiest method of contraception. There has been lot of technological advancements in contraceptive drugs such as development of emergency oral contraceptive pills. These contraceptive drugs are used for preventing unwanted pregnancy. These drugs are composition of one or more synthetic female sex hormones like progestin or progestin and estrogen. So it prevents pregnancy by blocking the normal and complex process of ovulation..It helps by prohibiting implantation of male hormones within the uterus, if it is taken within 2-3 days.
Simplicity of their usage makes it prominent contraceptive in the market. The other forms of contraceptive drugs are injectable and topical, had also witnessed strong growth rate. Moreover, the contraceptive drugs and devices market has witnessed growth due to the introduction of cheap contraceptives such as Pill-Plus, AG200-15 Contraceptive Patch and Sino-Implant (II). Female contraceptive devices are the fastest growing market. This market is further classified into, sub-dermal contraceptive implants, female condoms, contraceptive vaginal rings, intrauterine devices, contraceptive sponges, contraceptive diaphragm and non-surgical permanent contraception device.
Regional Insights
Geographically, the Contraceptive drugs and devices market is studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. Among these, North America and Europe is dominating the whole market owing to its sophisticated healthcare infrastructure, increasing awareness, availability of contraceptive drugs & devices, technologically advanced systems, and government initiatives. Over the forecast period, most of the domestic and international players are focusing on the emerging market, such as China, India, as these markets are lucrative by nature, and owe towards untapped opportunity, and these countries are growing rapidly in the contraceptive drugs and devices market.
Competitive Insights
The major players in the, Contraceptive drugs and devices market are Merck & Co., Bayer Healthcare AG, Warmer Chilcott Company inc., Church & Dwight Co. Inc., Pfizer Inc., Agile Therapeutics Inc., Mayer Laboratories Inc., BioSante Pharmaceuticals, Teva Pharmaceutical Industries Ltd, and Pantarhei Bioscience B.V.
